Prenatal Polysubstance Use and Attention-Deficit/Hyperactivity Disorder (ADHD)
Am J Prev Med
.
2024 Mar;66(3):548-550.
doi: 10.1016/j.amepre.2023.11.023.
Epub 2023 Dec 7.
Authors
Jennie E Ryan
1
,
Sean Esteban McCabe
2
,
Timothy E Wilens
3
,
Alexander Weigard
4
,
Brooke Worster
5
,
Philip Veliz
2
Affiliations
1
Thomas Jefferson University, College of Nursing, Philadelphia, Pennsylvania. Electronic address: Jennie.Ryan@jefferson.edu.
2
University of Michigan, School of Nursing, Center for the Study of Drugs, Alcohol Smoking and Health, Ann Arbor, Michigan.
3
Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
4
Department of Psychiatry, University of Michigan, University of Michigan Addiction Center, Ann Arbor, Michigan.
5
Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
PMID:
38070629
PMCID:
PMC10922843
(available on
2025-03-01
)
DOI:
10.1016/j.amepre.2023.11.023
No abstract available
MeSH terms
Attention Deficit Disorder with Hyperactivity* / epidemiology
Female
Humans
Pregnancy
Prenatal Exposure Delayed Effects* / epidemiology
Grants and funding
L40 DA056968/DA/NIDA NIH HHS/United States
P2C HD041028/HD/NICHD NIH HHS/United States
R01 DA031160/DA/NIDA NIH HHS/United States
UH3 DA050173/DA/NIDA NIH HHS/United States